Main Session
Sep
28
PQA 03 - PQA 03: Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer Biology
2550 - A Phase III, Non-Randomized, Open-Label, Two-Centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 in Patients With Suspected Persistent or Recurrent Prostate Cancer
Presenter(s)
Ben Merrick, MD - Western University, London, ON